Badische Peptide und Proteine (BPP) GmbH

Projekt → GLP-1 Receptor Agonist and GIP/GLP-1 Receptor Dual Agonist Therapeutics at the Intersection of Alcohol Use Disorder, Obesity, and Cardiometabolic Dysfunction. GLP-1 Receptor Agonist and GIP/GLP-1 Receptor Dual Agonist Therapeutics at the Intersection of Alcohol Use Disorder, Obesity, and… Beitrag ansehen → Projekt → Controlling Gene Expression with Synthetic Cell-Penetrating Transcription Factors The overarching goal of SynTra is the engineering of synthetic transcription factors (STFs) that can enter cells and activate or… Beitrag ansehen → Projekt → CenTral and PeRipheral NervoUs SyStem acTion of GIPR in ObEsity and Diabetes Obesity is a major health threat, but efficient pharmacotherapies are yet not available. First demonstrated by us to decrease bod… Beitrag ansehen → Projekt → Electrifying Peptide Synthesis for Directed Evolution of Artificial Enzymes Global climate and energy challenges require efficient, robust and scalable catalysts for the conversion of renewable energies. N… Beitrag ansehen → Projekt → Surface Transfer of Pathogens The STOP project will develop antimicrobial and antiviral nanocoatings that can be flexibly or permanently applied to high-touch… Beitrag ansehen → Projekt → Stapled peptide analogues as inhibitors of the CCR4-NOT complex to regulate the mRNA degradation RNA has gained significant attention in the past few decades due to its evolutionary role in gene regulations. In the regulation… Beitrag ansehen →